Gemcitabine and carboplatin in the treatment of locally advanced and metastatic non‐small cell lung cancer

Abstract

Gemcitabine-carboplatin combination chemotherapy is an effective and well-tolerated cytotoxic regimen among Malaysian patients with advanced NSCLC. A performance status of 1 or less was associated with a better survival.

A year in review: Respirology 2005 – Clinical science

“…The gemcitabine group, however, suffered from more myelosuppression, especially neutropenia and thrombocytopenia. A retrospective series of patients treated with a similar regime of gemcitabine and carboplatin also confirmed activity with a response rate of 27% 9 …”